Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia
Farah Kalagi, Sulaiman Bah, Yasmin Algindan · 2026
Read Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia by Farah Kalagi, Sulaiman Bah, Yasmin Algindan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571590.txt.
Description
Farah Kalagi, Sulaiman Bah, and Yasmin Algindan survey how doctors in Saudi Arabia prescribe GLP-1 drugs for teenage obesity. These drugs, first made for diabetes, are now widely used for weight loss, but real-world data on their use in adolescents in the kingdom are scarce. Their 2026 study ran a national survey of physicians and clinical nutritionists from December 2024 to July 2025. It asked who prescribes the drugs, for whom, and with what training and guidance.
The focus is variation by specialty: whether a teen gets the drug may depend on which door they enter. Barriers and training needs were explored alongside practice. The authors aim to guide national rules for a fast-growing, costly therapy. Their snapshot can anchor later studies of outcomes and safety in this age group.
Catalog record
| CREATOR | Farah Kalagi, Sulaiman Bah, Yasmin Algindan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |